National Community Pharmacists Association

Based in VA

🤖

AI Overview

With $15.4M in lobbying spend across 34 quarterly filings, National Community Pharmacists Association is one of the biggest lobbying spenders in Washington. They deploy 14 individual lobbyists Their lobbying covers 13 issue areas. Active from 2018 to 2025.

$15.4M
Total Spend
8
Years Active
1
Firms Hired
14
Lobbyists Deployed
13
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2018$1.3M
2019$1.3M
2020$1.5M
2021$3.7M
2022$3.2M
2023$1.4M
2024$1.8M
2025$1.3M

Issues Lobbied

Lobbying Firms

Lobbyists

Government Agencies Targeted

These are the government entities that National Community Pharmacists Association disclosed contacting in their lobbying filings.

Agriculture, Dept of (USDA)Centers For Medicare and Medicaid Services (CMS)Defense, Dept of (DOD)Drug Enforcement Administration (DEA)Food & Drug Administration (FDA)Government Accountability Office (GAO)Health & Human Services, Dept of (HHS)Health Resources & Services Administration (HRSA)HOUSE OF REPRESENTATIVESMedicare Payment Advisory Commission (MedPAC)Office of Management & Budget (OMB)Office of Natl Drug Control Policy (NDCP)Office of Personnel Management (OPM)SENATESubstance Abuse & Mental Health Services Administration (SAMHSA)White House OfficeEnvironmental Protection Agency (EPA)Small Business Administration (SBA)Internal Revenue Service (IRS)Labor, Dept of (DOL)+8 more
View all agency pressure data →

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Alcohol & Drug Abuse, Health Issues, Medicare/Medicaid, Defense, Budget/Appropriations and 8 more

Implementation of Public Law 114-198 pharmacy provisions;

Implementation of Public Law 114-255 pharmacy provisions;

H.R. 1854/S. 778, Prescription Drug Monitoring Act of 2017;

S 892 / H.R

S. 469, Affordable and Safe Prescription Drug Importation Act;

H.R. 1245, Affordable and Safe Prescription Drug Importation Act;

H.R. 1776, Improving Access to Affordable Prescription Drugs Act;

S.

H.R. 1316, Prescription Drug Price Transparency Act;

H.R. 1038, Improving Transparency and Accuracy in Medicare Part D Spending Act;

S. 413, Improving Transparency and Accuracy in Medicar

Tricare pharmacy working group

Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act;

H.R. 2430 the FDA Reauthorization Act (FDARA) of 2017;

S.934 FDA Reauthorization A

Related Analysis

Related Investigations

Similar Clients

Explore More

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.